Authors
Latest:
Mitigating Supply Chain Risk in Clinical TrialsOutlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.
Latest:
Can We Predict Drug Efficacy with Artificial Intelligence?Approaches such as machine learning, AI and neural networks are still in their infancy, but with AI companies rewriting the code for drug discovery, the implications in pharma are likely to be far ranging in the coming years.
Latest:
Consider an Enterprise Wide Project Management OfficeInterest in improved project management practices is growing in the fast-moving pharma industry.
Latest:
Investigative Site Placement Practices to Support Operation Warp SpeedComparing late-stage COVID-19 vaccine trials to historical practices.
Latest:
Bridging the Gap for Better Patient EngagementSurvey examines issues related to clinical trials quality and participation from the patients' view.
Latest:
SHARE-ing CDISC Standards Through a Cloud-based Metadata RepositoryCDISC executive talks about the creation of their cloud-based platform to free standards from PDF documents.
Latest:
The Missing Puzzle Piece of the Cloud Platform RevolutionAs clinical trials have become more complex and costly, traditional paper-based data management systems have increasingly proved impractical and ineffective. Cloud-based technologies fit the bill, and industry professionals have begun to recognize this reality and reap the benefits at an ever-increasing rate.
Latest:
Engaging Patients & Clinicians: Lessons from the PALM RegistryCase study evaluates the use of a mobile device tool for simplifying clinical trial patient enrollment and data collection.
Latest:
The ‘Pre’ Clinical Conversation: Dialogue Strategies UncoveredAudio study analyzes the communicative exchange factors between doctors and patients before enrollment-to better inform recruitment tactics.
Latest:
IRT Bridges Clinical and Supply Together—and Why It Matters4G Clinical head of marketing, Amy Ripston interviews Catherine Hall, director of operational excellence, at Sunovion to discuss how IRT bridges the gap between clinical and supply, and how interactive response technologies (IRT) can be leveraged to enable innovative trial designs.
Latest:
Six Steps to Ensuring Successful Clinical Trial ImagingAmit Vasanji, PhD and Brett A Hoover from ERT discuss technology and the steps to successful clinical trials.
Latest:
Leveraging Health IT to Improve Drug DevelopmentOutlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Latest:
The Future Fit of Wearables for Patient-Centric Clinical TrialsHarnessing these tools for successful integration and streamlining of processes.
Latest:
Leveraging Health IT to Improve Drug DevelopmentOutlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Latest:
The Success of Cell Therapies Will Depend on AutomationAutomation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.
Latest:
Anti-Microbial Resistance and the Role of VaccinesThis webcast will look at the scale of AMR, how CROs can assist in the development plan of new antimicrobials and where commercial development of new vaccines may be most effective. It will also provide insights and expert opinion on the potential success of antibacterial vaccination in controlling the rise of AMR and reducing the economic burden of infectious diseases. Live: North America: Thursday, Nov. 21, 2019 at 11am EST | 10am CST | 8am PST On demand available after airing until Nov. 21, 2020. Register free
Latest:
The Value of Empowered CRAs in Rare Disease StudiesExecutives from Atlantic Research Group discuss the importance of CRAs in rare disease clinical trials.
Latest:
Connecting Patients to Cutting-Edge CareHow can manufacturers ensure their clinical trial methods are evolving along with their product portfolio? It starts by taking a patient-focused approach to trial design, writes Susan Weidner.
Latest:
Unlocking the Potential of Risk-Based Quality MonitoringCOVID-19 may have accelerated the adoption of RBQM, but it is the intrinsic benefits that are cementing its continued use.
Latest:
The Case for Vendor Oversight for Small SponsorsExecutives from Edgerton Data Consulting and MedSurgPI discuss biopharmaceutical and medical device companies outsourcing one or more aspects of their clinical trials.
Latest:
The Case for Vendor Oversight for Small SponsorsExecutives from Edgerton Data Consulting and MedSurgPI discuss biopharmaceutical and medical device companies outsourcing one or more aspects of their clinical trials.
Latest:
The Case for Vendor Oversight for Small SponsorsExecutives from Edgerton Data Consulting and MedSurgPI discuss biopharmaceutical and medical device companies outsourcing one or more aspects of their clinical trials.
Latest:
The Importance of Biomarker ManagementExploring the benefits of capturing and integrating molecular biomarker data within clinical trials to build foundations for data assets.
Latest:
Increased Enrollment Efficiency With Point-of-Care Pre-ScreeningRetrospective analysis of clinical trial enrollment data evaluates the effectiveness of point-of-care testing in reducing later-screen failures.
Latest:
Increased Enrollment Efficiency With Point-of-Care Pre-ScreeningRetrospective analysis of clinical trial enrollment data evaluates the effectiveness of point-of-care testing in reducing later-screen failures.
Latest:
Increased Enrollment Efficiency With Point-of-Care Pre-ScreeningRetrospective analysis of clinical trial enrollment data evaluates the effectiveness of point-of-care testing in reducing later-screen failures.
